Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Better Buy: Enterprise Products Partners vs. Amgen

By Max Macaluso and Joel South - Mar 21, 2014 at 12:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

We've collected the most popular companies amongst Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better-Buy Tournament.

In today's ­first round match-up of The Motley Fool Better-Buy Tournament, Enterprise Products Partners squares off against Amgen in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each as they make the case for their stocks with the winner determined by you, the readers.

Motley Fool energy analyst Joel South thinks Enterprise Products Partners ( EPD -1.73% ) is the premier MLP investment in today's market. With an industry leading low cost of capital, Enterprise Products Partners is able to safely fund growth projects without having to increase its debt leverage ratio. This gives unit holders piece of mind while they collect hefty distribution yields every quarter. In fact, with access to cheap capital, no general partner to pay management fees to, and a booming North American oil and gas industry, Enterprise Products Partners has increased its distribution for 38 consecutive quarters. 

Motley Fool analyst Max Macaluso makes the case for Amgen ( AMGN 0.96% ) to move on to the next round. The company has matured into one of the biggest biotechs on the planet through its solid lineup of blockbuster drugs, and it has continued to diversify its drug pipeline. In addition, Amgen is one of the few biotechs to offer a dividend.

Watch these analysts square off in the video below and then vote for a winner. Then check out the other companies in the Motley Fool Better-Buy Bracket

This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Cast your vote in the poll below the video!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Amgen Inc. Stock Quote
Amgen Inc.
AMGN
$200.80 (0.96%) $1.92
Enterprise Products Partners L.P. Stock Quote
Enterprise Products Partners L.P.
EPD
$21.02 (-1.73%) $0.37

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
656%
 
S&P 500 Returns
144%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.